Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
TCTR |
Last refreshed on:
|
29 April 2024 |
Main ID: |
TCTR20141128001 |
Date of registration:
|
28/11/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Study the effects of Andrographis paniculata on platelet aggregation in Thai healthy volunteers: the pilot study
|
Scientific title:
|
Study the effects of Andrographis paniculata on platelet aggregation in Thai healthy volunteers: the pilot study |
Date of first enrolment:
|
25/04/2014 |
Target sample size:
|
|
Recruitment status: |
Completed |
URL:
|
https://www.thaiclinicaltrials.org/show/TCTR20141128001 |
Study type:
|
Interventional |
Study design:
|
Non-randomized
|
Phase:
|
Phase 1
|
|
Countries of recruitment
|
Thailand
| | | | | | | |
Contacts
|
Name:
|
Assoc. Prof. Pravit
Akarasereenont |
Address:
|
2 Wanglang Road Bangkoknoi
10700
Bangkok
Thailand |
Telephone:
|
+662-419-5227 |
Email:
|
pravit.auk@mahidol.ac.th |
Affiliation:
|
Faculty of Medicine Siriraj Hospital |
|
Name:
|
Assoc. Prof. Pravit
Akarasereenont |
Address:
|
2 Wanglang Road Bangkoknoi
10700
Bangkok
Thailand |
Telephone:
|
+662-419-5227 |
Email:
|
pravit.auk@mahidol.ac.th |
Affiliation:
|
Faculty of Medicine Siriraj Hospital |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Male or female age between 25-60 years
2. Body mass index (BMI) between 18 to 24 kg/m^2
3. Who has been determined healthy physical examination, medical history, and vital signs
4. Female, non pregnant or use the contraceptive or not currently breast feeding and have negative pregnancy test
5. Who be willing to participate and signed the informed consent form
Exclusion criteria: 1. Who has history usage of other drugs, especially which can effect platelet aggregation
2. Who has history of allergic reactions or allergy to NSAIDs, Andrographis paniculata or its derivative compounds
3. Who is no smoke and alcohol
4. Who has donated blood within last 90 days before participate
Age minimum:
25 Years
Age maximum:
60 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
healthy human volunteers
|
Intervention(s)
|
All healthy volunteers was fasting for 12 hour before received 2 g of Andrographis paniculata capsules for 3 times in 4 hour intervals. Compared the effects of Andrographis paniculata before and after 2 and 24 hour administration.
|
Active Comparator Drug
|
Andrographis paniculata
|
Primary Outcome(s)
|
A. paniculata has the effect on platelet aggregation in human platelet 0, 2, and 24 hour after A. paniculata administration aggregation assay
|
Secondary Outcome(s)
|
A. paniculata has the effect on COX activity and P-selectin in human platelet aggregation 0, 2, and 24 hour after A. paniculata administration RT-PCR, Western blot and ELISA
|
Source(s) of Monetary Support
|
Faculty of Medicine Siriraj Hospital
|
Ethics review
|
Status: Submitted, approved
Approval date:
Contact:
Siriraj Institutional Review Board
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
28/05/2014 |
URL:
|
|
|
|